How Fast Are Antidepressants?
The DOI matches its Crossref record.
Abstract
BACKGROUND: For years, investigators have tried to determine the speed of onset of antidepressant drugs. Claims that particular drugs may produce a faster response in patients than other agents have been made, but such claims have never been confirmed. METHOD: The authors reviewed reports from studies of the speed of onset of antidepressant therapies and other studies that revealed information on this topic. We compiled a list of factors that can affect the results of such studies and interpretations of study results. In addition, we reviewed literature concerned with methods of speeding up antidepressant responses. RESULTS: No antidepressant medication currently available has been shown conclusively to have a more rapid onset of action than any other. However, some methods of augmentation may have the potential to speed responses. Somatic therapies such as electroconvulsive therapy, phototherapy, and therapeutic sleep deprivation may be the fastest options available at this time. CONCLUSION: All available antidepressant medications are usually taken for several weeks before future responders will display a significant therapeutic benefit. If a patient does not show at least a 20% improvement within the first 2 to 4 weeks of treatment, the treatment regimen should be altered. For patients who do show early benefits from a medication trial, one can expect additional benefits to accrue over an 8- to 12-week period and to improve overall outcome compared with those slower to respond. Future trials need to address methodological confounds, but a truly "faster antidepressant" will probably require new neuroscience technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406
“treatment, there may, in fact, be early benefits.(17,18) Apparent early response to active treatment may simply reflect chance, or there may be a true early effect of SSRI treatment that individual studies have usually”
BackgroundRelief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study
Kellner, C. H., Fink, M., Knapp, R., Petrides, G., Husain, M., Rummans, T., Mueller, M., Bernstein, H., Rasmussen, K., O’Connor, K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.977 · Cited by 345
Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252
“…was at variance with the then current view that despite the almost immediate impact of ADs on the functioning of central monoamine transmitter systems, the clinical actions of the drugs ‘lag’, that is, were not thought to occur until after 2–3 weeks of treatment (see Gelenberg and Chesen, 2000).”
BackgroundStratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Arias, B., Catalán, R., Gastó, C., Gutiérrez, B., & Fañanás, L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095350.32154.73 · Cited by 174
“However, SSRIs present some disadvantages, including a delay of 2 or 3 weeks before the first effects in clinical response become evident.(2,3) In this sense, there is consensus that optimal antidepressant-induced improvement of depression symptoms is slow, taking 6–12 weeks to occur.”
BackgroundConvergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Delayed pharmacological effects of antidepressants
Frazer, A., & Benmansour, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001015 · Cited by 160
Sackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
Lapiz, M. D. S., Bondi, C. O., & Morilak, D. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301235 · Cited by 95
“The beneficial effects of ADs are only evident after continued chronic administration, the socalled ‘therapeutic lag’ (Gelenberg and Chesen, 2000).”
BackgroundRapid-acting antidepressant strategies: mechanisms of action
Bunney, B. G., & Bunney, W. E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000927 · Cited by 79
Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression
Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023982 · Cited by 70
Third-Generation Antidepressants: Do They Offer Advantages Over the SSRIs?
Olver, J. S., Burrows, G. D., & Norman, T. R. (2001) · CNS Drugs · doi:10.2165/00023210-200115120-00004 · Cited by 63
Bondi, C. O., Barrera, G., Lapiz, M. D. S., Bedard, T., Mahan, A., & Morilak, D. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.015 · Cited by 56
Mechanisms of SSRI Therapy and Discontinuation
Sharp, T., & Collins, H. (2023) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2023_452 · Cited by 55
Bechtholt, A. J., Valentino, R. J., & Lucki, I. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301616 · Cited by 40
“Although antidepressants are frequently prescribed to treat both depression and anxiety, it is not clear why there is a delay of up to several weeks before they produce a significant clinical response (Gelenberg and Chesen, 2000).”
A predictive coding framework for understanding major depression
Gilbert, J. R., Wusinich, C., & Zarate, C. A. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.787495 · Cited by 38
Molecular and Cellular Mechanisms of Antidepressant Action
Sharp, T. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_216 · Cited by 36
Frecska, E., Perenyi, A., & Arato, M. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00072-6 · Cited by 3
“Third, it is a valuable augmentation strategy in treatmentrefractory depression (Gelenberg and Chesen, 2000).”
Background
Metadata
- Authors
- Gelenberg, A. J., & Chesen, C. L.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2000-10-15
- Volume
- 61
- Issue
- 10
- Pages
- 712-721
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2074657008
- Cited by
- 127
- References
- 0
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.